I better just throw this one into the closet for a year. I guess that quick dime by next week is out of the question.
However, I've always had a longer term view and I can't imagine it taking more than 3-6 months for Integumen to be in the field with an anxious sales force that has an arsenal of established sales contacts, indirectly via Venn.
I knew a couple of gals who sold pharmaceutical products in the past and and they met frequently with their clients to manage their accounts and introduce new products.
Since the new sales team likely will have a strong client base already intact, it should be very easy to introduce and sell a new stealth, medically based, skin care line.
I'm hopeful that in a year from now Integumen can already have some very significant revenue, especially if the goal is to get listed on the London Stock Exchange.
I don't know how that would work (anyone know?) but since it's a different exchange, I'm guessing that it would essentially look like a new IPO that would come with a nice biotech price point as well. I guess I better dream of five dollars in a year instead of a dime next week. (At least the dream will make it fun!).
Who knows what's going to happen but the long term play for me is that we have a great product line that seemingly needed a professional worldwide biotech sales force to bring it to life and I think that's what were about to get. I can wait for a year since the skin care industry is a $100+ billion market worldwide according to my Google research.
Just my opinion; not investment advice!
